Business
Protalix BioTherapeutics to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein expression system, today announced that it will participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference, taking place on Tuesday, May 20, 2025 at the Nasdaq headquarters in New York City, New York.
About this update from Protalix Biotherapeutics, Inc. (de)
[{"type":"text","content":"CARMIEL, Israel, May 14, 2025 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein expression system, today announced that it will participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference, taking place on Tuesday, May 20, 2025 at the Nasdaq headquarters in New York City, New York.","length":521,"tagName":"p"},{"type":"image","alt":"Protalix Biotherapeutics Logo","displaySize":"","headline":null,"caption":"Protalix Biotherapeutics Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":121,"url":"https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JqTp0X7VmxnrsXQUFDueUg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIxMztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f2174d5c59bc5e34e9e5ea6a94c7eeba","width":400,"height":121}}},{"type":"text","content":"Eyal Rubin, the Company's Sr. Vice President and Chief Financial Officer, will deliver a company presentation and be available for one-on-one investor meetings throughout the event.","length":190,"tagName":"p"},{"type":"text","content":"Investors interested in scheduling a meeting with the Company's management team should contact their H.C. Wainwright representative or email [email protected].","length":164,"tagName":"p"},{"type":"text","content":"Event Details","length":13,"tagName":"p"},{"type":"text","content":"Conference: 3rd Annual H.C. Wainwright BioConnect Investor Conference","length":81,"tagName":"p"},{"type":"text","content":"Date: Tuesday, May 20, 2025","length":116,"tagName":"p"},{"type":"text","content":"Location: Nasdaq World Headquarters in New York City (151 W. 43rd Street)","length":115,"tagName":"p"},{"type":"text","content":"Webcast Details","length":15,"tagName":"p"},{"type":"text","content":"A webcast of the live presentation will be available at 4:30 pm, Eastern Daylight Time (EDT), via the following links:","length":128,"tagName":"p"},{"type":"text","conte...